Competitive Intelligence 2014: World Animal Health Market Outlook and Leading Suppliers' Business Strategies and Marketing Tactics

Venture Planning Group
March 3, 2014
80 Pages - SKU: VPG5213319
Countries covered: Global

Competitive Intelligence 2014: World Animal Health Market Outlook and Leading Suppliers' Business Strategies and Marketing Tactics

This new report from Venture Planning Group provides world animal health market outlook and leading suppliers' business strategies and marketing tactics. The report presents a worldwide strategic overview of the animal health market, including:
  • Five-year forecasts for:
- Major market segments - Key geographic regions
  • Assessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion of such issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics and other technologies.
The company profiles include:
  • Specific business, new product development and marketing strategies.
  • Anticipated acquisitions, joint ventures and divestitures.
  • Major strengths and weaknesses.
  • Sales force size in the U.S. and other markets.
  • Promotional tactics.
  • Distribution approaches.
  • Product service and support.
  • Customer relations.
Contains 80 pages and 6 tables

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.



More Drug Discovery reports by Venture Planning Group

Competitive Intelligence 2014: Analysis of the Global Animal Health Market, and Leading Suppliers' Marketing Tactics and Technological Know-How by Venture Planning Group
Competitive Intelligence 2014: Analysis of the Global Animal Health Market, and Leading Suppliers' Marketing Tactics and Technological Know-HowThis new report from Venture Planning Group provides ...
Analysis of the Sexually-Transmitted Disease Testing Market in Europe: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis by Venture Planning Group
This new 318-page report from Venture Planning Group, Analysis of the Sexually-Transmitted Disease Testing Market in Europe: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis, provides analysis ...
Analysis of the Sexually-Transmitted Disease Testing Market in the US: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis by Venture Planning Group
This new 278-page report from Venture Planning Group, Analysis of the Sexually-Transmitted Disease Testing Market in the US: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis, provides ...
Infectious Diseases in Europe: Market Segment Forecasts and Supplier Shares by Venture Planning Group
This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test.This comprehensive European survey is ...
See all reports like this >>

More Global Drug Discovery reports

Insomnia Global Clinical Trials Review, H2, 2014 by GlobalData
Insomnia Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, “Insomnia Global Clinical Trials Review, H2, 2014 provides data on the Insomnia clinical trial scenario. ...
Global Rheumatoid Arthritis Drugs Market : 2014-2018 by TechNavio - Infiniti Research Ltd.
Press ReleaseTechNavio Announces the Publication of its Research Report - Global Rheumatoid Arthritis Drugs Market 2014-2018TechNavio recognizes the following companies as the key players in ...
Global Macular Edema Market : 2014-2018 by TechNavio - Infiniti Research Ltd.
Press ReleaseTechNavio Announces the Publication of its Research Report - Global Macular Edema Market 2014-2018TechNavio recognizes the following companies as the key players in the ...
A Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS by Frost & Sullivan
A Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS Key Findings Human Immunodeficiency Virus (HIV) Antiretrovirals The 2006 launch ...
See all reports like this >>

 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 3,450  
    Global Site License Fulfilled by Publisher  USD 7,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!